Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature
暂无分享,去创建一个
C. Hoggart | L. Coin | M. Kaforou | V. Wright | M. Hibberd | M. Levin | J. Kanegaye | J. Burns | A. Tremoulet | T. Kuijpers | H. Eleftherohorinou | C. Shimizu | M. Glodé | J. Herberg | L. Hoang | A. M. Barendregt | Maurice Berk | Stephanie Menikou | Hannah Shailes | S. Gormley
[1] Clive J. Hoggart,et al. PReMS: Parallel Regularised Regression Model Search for sparse bio-signature discovery , 2018, bioRxiv.
[2] Sohee Park,et al. Epidemiology and Clinical Features of Kawasaki Disease in South Korea, 2012–2014 , 2017, The Pediatric infectious disease journal.
[3] B. McCrindle,et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association , 2017, Circulation.
[4] Xuejuan Gao,et al. Sets of serum exosomal microRNAs as candidate diagnostic biomarkers for Kawasaki disease , 2017, Scientific Reports.
[5] Sung-Chou Li,et al. Next-generation sequencing identifies micro-RNA-based biomarker panel for Kawasaki disease. , 2016, The Journal of allergy and clinical immunology.
[6] C. Hoggart,et al. Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile Children. , 2016, JAMA.
[7] J. Yu. Use of corticosteroids during acute phase of Kawasaki disease. , 2015, World journal of clinical pediatrics.
[8] K. Kotani,et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. , 2015, Journal of epidemiology.
[9] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[10] C. Khor,et al. Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease , 2014, Genome Medicine.
[11] O. Ramilo,et al. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial , 2014, The Lancet.
[12] L. Coin,et al. Diagnosis of childhood tuberculosis and host RNA expression in Africa. , 2014, The New England journal of medicine.
[13] Chin‐Yun Lee,et al. Estimation of the incidence of Kawasaki disease in Taiwan. A comparison of two data sources: nationwide hospital survey and national health insurance claims. , 2014, Pediatrics and neonatology.
[14] E. Frangou,et al. Gene expression and regulation in systemic lupus erythematosus , 2013, European journal of clinical investigation.
[15] Colin G Fink,et al. Transcriptomic Profiling in Childhood H1N1/09 Influenza Reveals Reduced Expression of Protein Synthesis Genes , 2013, The Journal of infectious diseases.
[16] S. Crosby,et al. Gene expression profiles in febrile children with defined viral and bacterial infection , 2013, Proceedings of the National Academy of Sciences.
[17] M. El-Adawy,et al. Preventing Coronary Artery Abnormalities: A Need for Earlier Diagnosis and Treatment of Kawasaki Disease , 2012, The Pediatric infectious disease journal.
[18] J. Burns,et al. Kawasaki disease: late cardiovascular sequelae , 2012, Current opinion in cardiology.
[19] T. Matsuishi,et al. Long-Term Prognosis of Patients With Kawasaki Disease Complicated by Giant Coronary Aneurysms: A Single-Institution Experience , 2011, Circulation.
[20] C. Weinberg,et al. Gene expression profiles from discordant monozygotic twins suggest that molecular pathways are shared among multiple systemic autoimmune diseases , 2011, Arthritis research & therapy.
[21] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[22] Calvin Lin,et al. Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance. , 2010, Human immunology.
[23] R. Holman,et al. Hospitalizations for Kawasaki Syndrome Among Children in the United States, 1997–2007 , 2010, The Pediatric infectious disease journal.
[24] Sumio Watanabe,et al. Asymptotic Equivalence of Bayes Cross Validation and Widely Applicable Information Criterion in Singular Learning Theory , 2010, J. Mach. Learn. Res..
[25] D. Relman,et al. Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection. , 2009, The Journal of infectious diseases.
[26] T. K. van den Berg,et al. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. , 2009, Blood.
[27] M. Goldacre,et al. Kawasaki Disease in England: Ethnicity, Deprivation, and Respiratory Pathogens , 2009, The Pediatric infectious disease journal.
[28] J. Abe,et al. Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease. , 2008, The Journal of allergy and clinical immunology.
[29] Pan Du,et al. lumi: a pipeline for processing Illumina microarray , 2008, Bioinform..
[30] P. Brown,et al. Gene-expression patterns reveal underlying biological processes in Kawasaki disease , 2007, Genome Biology.
[31] S. Colan,et al. Delayed Diagnosis of Kawasaki Disease: What Are the Risk Factors? , 2007, Pediatrics.
[32] Junbao Du,et al. VALGANCICLOVIR FOR CONGENITAL CMV INFECTION: A PILOT STUDY ON PLASMA CONCENTRATION IN NEWBORNS AND INFANTS , 2007, The Pediatric infectious disease journal.
[33] J. Banchereau,et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. , 2007, Blood.
[34] J. Abe,et al. Gene Expression Profiling of the Effect of High-Dose Intravenous Ig in Patients with Kawasaki Disease1 , 2005, The Journal of Immunology.
[35] Kunihiko Kobayashi,et al. Differential gene expression of S100 protein family in leukocytes from patients with Kawasaki disease , 2005, European Journal of Pediatrics.
[36] H. Zou,et al. Regularization and variable selection via the elastic net , 2005 .
[37] Walter R Wilson,et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association , 2004, Pediatrics.
[38] M. Suarez‐Almazor,et al. International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 , 2004 .
[39] R. Holman,et al. Risk factors for bronchiolitis-associated deaths among infants in the United States , 2003, The Pediatric infectious disease journal.
[40] D. Wilkinson. Gene Expression Patterns , 2002, Brain Research.
[41] K Hashino,et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. , 1996, Circulation.
[42] H. Yanagawa,et al. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. , 1974, Pediatrics.
[43] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.
[44] Y. Saeki,et al. Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients. , 2005, DNA research : an international journal for rapid publication of reports on genes and genomes.
[45] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[46] José M Bernardo and Adrian F M Smith. Bayesian Theory , 2001 .
[47] R. Tibshirani. Regression Shrinkage and Selection via the Lasso , 1996 .
[48] W. Youden,et al. Index for rating diagnostic tests , 1950, Cancer.